T. Rowe Price Associates’s Intuitive Surgical ISRG Stock Holding History

T. Rowe Price Associates’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.77B	Sell	12,520,007 -34,756	-0.3%	-$17.6M	0.67%	19
2025 Q4	$7.11B	Sell	12,554,763 -264,027	-2%	-$141M	0.77%	17
2025 Q3	$5.73B	Sell	12,818,790 -596,681	-4%	-$286M	0.61%	21
2025 Q2	$7.29B	Sell	13,415,471 -367,772	-3%	-$192M	0.83%	17
2025 Q1	$6.83B	Sell	13,783,243 -686,369	-5%	-$380M	0.84%	16
2024 Q4	$7.55B	Sell	14,469,612 -125,824	-0.9%	-$65.5M	0.87%	16
2024 Q3	$7.17B	Sell	14,595,436 -1,246,054	-8%	-$580M	0.83%	14
2024 Q2	$7.05B	Sell	15,841,490 -688,759	-4%	-$274M	0.84%	13
2024 Q1	$6.6B	Sell	16,530,249 -443,017	-3%	-$167M	0.81%	14
2023 Q4	$5.73B	Buy	16,973,266 +272,741	+2%	+$81.3M	0.77%	17
2023 Q3	$4.88B	Sell	16,700,525 -2,321,570	-12%	-$725M	0.72%	20
2023 Q2	$6.5B	Sell	19,022,095 -1,402,172	-7%	-$424M	0.91%	14
2023 Q1	$5.22B	Sell	20,424,267 -451,175	-2%	-$111M	0.78%	21
2022 Q4	$5.54B	Sell	20,875,442 -3,651,588	-15%	-$890M	0.89%	14
2022 Q3	$4.61B	Sell	24,527,030 -1,165,705	-5%	-$250M	0.75%	19
2022 Q2	$5.16B	Buy	25,692,735 +816,066	+3%	+$191M	0.65%	22
2022 Q1	$7.5B	Buy	24,876,669 +120,648	+0.5%	+$35.2M	0.76%	19
2021 Q4	$8.89B	Sell	24,756,021 -1,167,714	-5%	-$402M	0.8%	18
2021 Q3	$8.59B	Sell	25,923,735 -998,403	-4%	-$335M	0.81%	17
2021 Q2	$8.25B	Sell	26,922,138 -60,192	-0.2%	-$16.9M	0.77%	19
2021 Q1	$6.65B	Sell	26,982,330 -1,817,946	-6%	-$457M	0.67%	24
2020 Q4	$7.85B	Sell	28,800,276 -1,664,370	-5%	-$413M	0.81%	17
2020 Q3	$7.21B	Sell	30,464,646 -774,900	-2%	-$174M	0.83%	17
2020 Q2	$5.93B	Buy	31,239,546 +452,526	+1%	+$81.1M	0.75%	19
2020 Q1	$5.08B	Sell	30,787,020 -255,327	-0.8%	-$46.8M	0.8%	20
2019 Q4	$6.12B	Sell	31,042,347 -143,139	-0.5%	-$26.8M	0.79%	20
2019 Q3	$5.61B	Buy	31,185,486 +519,417	+2%	+$89.8M	0.79%	18
2019 Q2	$5.36B	Sell	30,666,069 -605,811	-2%	-$104M	0.75%	17
2019 Q1	$5.95B	Buy	31,271,880 +100,362	+0.3%	+$17.8M	0.87%	13
2018 Q4	$4.98B	Buy	31,171,518 +1,033,047	+3%	+$175M	0.84%	16
2018 Q3	$5.77B	Sell	30,138,471 -1,133,352	-4%	-$201M	0.84%	15
2018 Q2	$4.99B	Buy	31,271,823 +27,519	+0.1%	+$4.2M	0.76%	17
2018 Q1	$4.3B	Sell	31,244,304 -3,417,117	-10%	-$477M	0.68%	23
2017 Q4	$4.22B	Sell	34,661,421 -4,117,878	-11%	-$515M	0.68%	20
2017 Q3	$4.51B	Sell	38,779,299 -4,675,131	-11%	-$509M	0.77%	18
2017 Q2	$4.52B	Sell	43,454,430 -3,725,910	-8%	-$358M	0.81%	17
2017 Q1	$4.02B	Buy	47,180,340 +352,638	+0.8%	+$27.9M	0.75%	18
2016 Q4	$3.3B	Buy	46,827,702 +2,004,174	+4%	+$147M	0.66%	20
2016 Q3	$3.61B	Sell	44,823,528 -4,074,714	-8%	-$312M	0.73%	19
2016 Q2	$3.59B	Sell	48,898,242 -1,476,531	-3%	-$104M	0.76%	21
2016 Q1	$3.36B	Sell	50,374,773 -6,894,018	-12%	-$427M	0.72%	23
2015 Q4	$3.48B	Buy	57,268,791 +2,201,931	+4%	+$124M	0.73%	25
2015 Q3	$2.81B	Buy	55,066,860 +562,194	+1%	+$31.8M	0.63%	30
2015 Q2	$2.93B	Buy	54,504,666 +2,624,067	+5%	+$147M	0.6%	30
2015 Q1	$2.91B	Buy	51,880,599 +169,299	+0.3%	+$9.58M	0.6%	27
2014 Q4	$3.04B	Buy	51,711,300 +946,008	+2%	+$52.7M	0.65%	20
2014 Q3	$2.6B	Buy	50,765,292 +12,376,404	+32%	+$614M	0.57%	34
2014 Q2	$1.76B	Buy	38,388,888 +18,500,328	+93%	+$816M	0.38%	61
2014 Q1	$968M	Buy	19,888,560 +13,837,923	+229%	+$652M	0.22%	118
2013 Q4	$258M	Buy	6,050,637 +3,777,390	+166%	+$159M	0.06%	370
2013 Q3	$95M	Buy	2,273,247 +386,010	+20%	+$17M	0.02%	605
2013 Q2	$106M	Buy	+1,887,237	New	+$104M	0.03%	555